Severin Schwan News
Most Popular Severin Schwan Story
Roche results spotlight targeted-drug strategy
After a series of Big Pharma letdowns, Roche's ($RHHBY) results announcement was a series of positives: An increase in 2011 net income, a sales-growth forecast in the "low to mid-single digits," and Read more...
Latest Headlines
- February 1, 2012
- December 22, 2011
- December 7, 2011
- October 21, 2011
- September 19, 2011
- September 1, 2011
- February 7, 2011
- February 2, 2011
- December 3, 2010
- September 15, 2010
- May 27, 2010
- November 25, 2009
- October 13, 2009
- October 7, 2009
- May 11, 2009
- February 9, 2009
- February 5, 2009
- December 8, 2008
- October 29, 2008
- July 23, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
